Concepedia

David Butler

DB

38

Publications

4.9K

Citations

27

H-Index

1972

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Neural Stem Cell Institute

University of Connecticut

University of North Carolina at Pembroke

Children's Mercy Hospital

David Butler is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, cell biology, and pharmacology.

ORCID

Top concepts

Publications per year

1972–2021

38

Publications

38

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**

Muthusamy Jayaraman, Steven M. Ansell, Barbara L. Mui et al. · Angewandte Chemie International Edition · 2012 · 1.2K citations · Full text

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Maria Frank-Kamenetsky, Aldo Grefhorst, Norma N. Anderson et al. · Proceedings of the National Academy of Sciences · 2008 · 635 citations · Full text

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics

Martin A. Maier, Muthusamy Jayaraman, Shigeo Matsuda et al. · Molecular Therapy · 2013 · 594 citations · Full text

Analysis of Gunshot Residue and Associated Materials—A Review

Oliver Dalby, David Butler, Jason Birkett · Journal of Forensic Sciences · 2010 · 400 citations

1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues:  A Promising Class of Monoamine Uptake Inhibitors

Peter C. Meltzer, David Butler, Jeffrey R. Deschamps et al. · Journal of Medicinal Chemistry · 2006 · 399 citations · Full text

, , +16

Rows per page

1–5 of 38